Verteporfin-Loaded Anisotropic Poly(Beta-Amino Ester)-Based Micelles Demonstrate Brain Cancer-Selective Cytotoxicity and Enhanced Pharmacokinetics

James G Shamul,1,2,* Sagar R Shah,1–3,* Jayoung Kim,1,2 Paula Schiapparelli,3 Carla A Vazquez-Ramos,3 Ben J Lee,1,2 Kisha K Patel,1,2 Alyssa Shin,1,2 Alfredo Quinones-Hinojosa,3 Jordan J Green1,2,4–6 1Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimo...

Full description

Bibliographic Details
Main Authors: Shamul JG, Shah SR, Kim J, Schiapparelli P, Vazquez-Ramos CA, Lee BJ, Patel KK, Shin A, Quinones-Hinojosa A, Green JJ
Format: Article
Language:English
Published: Dove Medical Press 2019-12-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/verteporfin-loaded-anisotropic-polybeta-amino-ester-based-micelles-dem-peer-reviewed-article-IJN
_version_ 1818751676760195072
author Shamul JG
Shah SR
Kim J
Schiapparelli P
Vazquez-Ramos CA
Lee BJ
Patel KK
Shin A
Quinones-Hinojosa A
Green JJ
author_facet Shamul JG
Shah SR
Kim J
Schiapparelli P
Vazquez-Ramos CA
Lee BJ
Patel KK
Shin A
Quinones-Hinojosa A
Green JJ
author_sort Shamul JG
collection DOAJ
description James G Shamul,1,2,* Sagar R Shah,1–3,* Jayoung Kim,1,2 Paula Schiapparelli,3 Carla A Vazquez-Ramos,3 Ben J Lee,1,2 Kisha K Patel,1,2 Alyssa Shin,1,2 Alfredo Quinones-Hinojosa,3 Jordan J Green1,2,4–6 1Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, MD 21231, USA; 2Translational Tissue Engineering Center and Institute for NanoBioTechnology, Johns Hopkins School of Medicine, Baltimore, MD 21231, USA; 3Department of Neurosurgery, Mayo Clinic, Jacksonville, FL 32224, USA; 4Department of Neurosurgery, Johns Hopkins Hospital, Baltimore, MD 21231, USA; 5Department of Oncology, The Sidney Kimmel Comprehensive Cancer, and The Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Johns Hopkins School of Medicine, Baltimore, MD 21231, USA; 6Department of Ophthalmology, Department of Materials Science and Engineering, and Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD 21231, USA*These authors contributed equally to this workCorrespondence: Alfredo Quinones-Hinojosa; Jordan J Green Email Quinones-Hinojosa.Alfredo@mayo.edu; green@jhu.eduBackground: Nanomedicine can improve traditional therapies by enhancing the controlled release of drugs at targeted tissues in the body. However, there still exists disease- and therapy-specific barriers that limit the efficacy of such treatments. A major challenge in developing effective therapies for one of the most aggressive brain tumors, glioblastoma (GBM), is affecting brain cancer cells while avoiding damage to the surrounding healthy brain parenchyma. Here, we developed poly(ethylene glycol) (PEG)-poly(beta-amino ester) (PBAE) (PEG-PBAE)-based micelles encapsulating verteporfin (VP) to increase tumor-specific targeting.Methods: Biodegradable, pH-sensitive micelles of different shapes were synthesized via nanoprecipitation using two different triblock PEG-PBAE-PEG copolymers varying in their relative hydrophobicity. The anti-tumor efficacy of verteporfin loaded in these anisotropic and spherical micelles was evaluated in vitro using patient-derived primary GBM cells.Results: For anisotropic micelles, uptake efficiency was ∼100% in GBM cells (GBM1A and JHGBM612) while only 46% in normal human astrocytes (NHA) at 15.6 nM VP (p ≤ 0.0001). Cell killing of GBM1A and JHGBM612 vs NHA was 52% and 77% vs 29%, respectively, at 24 hrs post-treatment of 125 nM VP-encapsulated in anisotropic micelles (p ≤ 0.0001), demonstrating the tumor cell-specific selectivity of VP. Moreover, anisotropic micelles showed an approximately fivefold longer half-life in blood circulation than the analogous spherical micelles in a GBM xenograft model in mice. In this model, micelle accumulation to tumors was significantly greater for anisotropic micelle-treated mice compared to spherical micelle-treated mice at both 8 hrs (∼1.8-fold greater, p ≤ 0.001) and 24 hrs (∼2.1-fold greater, p ≤ 0.0001).Conclusion: Overall, this work highlights the promise of a biodegradable anisotropic micelle system to overcome multiple drug delivery challenges and enhance efficacy and safety for the treatment of brain cancer.Keywords: GBM, verteporfin, micelle, anisotropic, poly(ethylene glycol), PEG, poly(beta-amino ester), PBAE
first_indexed 2024-12-18T04:39:22Z
format Article
id doaj.art-2496eb01f1894d55b0f3730a936e4f48
institution Directory Open Access Journal
issn 1178-2013
language English
last_indexed 2024-12-18T04:39:22Z
publishDate 2019-12-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj.art-2496eb01f1894d55b0f3730a936e4f482022-12-21T21:20:46ZengDove Medical PressInternational Journal of Nanomedicine1178-20132019-12-01Volume 14100471006050659Verteporfin-Loaded Anisotropic Poly(Beta-Amino Ester)-Based Micelles Demonstrate Brain Cancer-Selective Cytotoxicity and Enhanced PharmacokineticsShamul JGShah SRKim JSchiapparelli PVazquez-Ramos CALee BJPatel KKShin AQuinones-Hinojosa AGreen JJJames G Shamul,1,2,* Sagar R Shah,1–3,* Jayoung Kim,1,2 Paula Schiapparelli,3 Carla A Vazquez-Ramos,3 Ben J Lee,1,2 Kisha K Patel,1,2 Alyssa Shin,1,2 Alfredo Quinones-Hinojosa,3 Jordan J Green1,2,4–6 1Department of Biomedical Engineering, Johns Hopkins School of Medicine, Baltimore, MD 21231, USA; 2Translational Tissue Engineering Center and Institute for NanoBioTechnology, Johns Hopkins School of Medicine, Baltimore, MD 21231, USA; 3Department of Neurosurgery, Mayo Clinic, Jacksonville, FL 32224, USA; 4Department of Neurosurgery, Johns Hopkins Hospital, Baltimore, MD 21231, USA; 5Department of Oncology, The Sidney Kimmel Comprehensive Cancer, and The Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Johns Hopkins School of Medicine, Baltimore, MD 21231, USA; 6Department of Ophthalmology, Department of Materials Science and Engineering, and Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD 21231, USA*These authors contributed equally to this workCorrespondence: Alfredo Quinones-Hinojosa; Jordan J Green Email Quinones-Hinojosa.Alfredo@mayo.edu; green@jhu.eduBackground: Nanomedicine can improve traditional therapies by enhancing the controlled release of drugs at targeted tissues in the body. However, there still exists disease- and therapy-specific barriers that limit the efficacy of such treatments. A major challenge in developing effective therapies for one of the most aggressive brain tumors, glioblastoma (GBM), is affecting brain cancer cells while avoiding damage to the surrounding healthy brain parenchyma. Here, we developed poly(ethylene glycol) (PEG)-poly(beta-amino ester) (PBAE) (PEG-PBAE)-based micelles encapsulating verteporfin (VP) to increase tumor-specific targeting.Methods: Biodegradable, pH-sensitive micelles of different shapes were synthesized via nanoprecipitation using two different triblock PEG-PBAE-PEG copolymers varying in their relative hydrophobicity. The anti-tumor efficacy of verteporfin loaded in these anisotropic and spherical micelles was evaluated in vitro using patient-derived primary GBM cells.Results: For anisotropic micelles, uptake efficiency was ∼100% in GBM cells (GBM1A and JHGBM612) while only 46% in normal human astrocytes (NHA) at 15.6 nM VP (p ≤ 0.0001). Cell killing of GBM1A and JHGBM612 vs NHA was 52% and 77% vs 29%, respectively, at 24 hrs post-treatment of 125 nM VP-encapsulated in anisotropic micelles (p ≤ 0.0001), demonstrating the tumor cell-specific selectivity of VP. Moreover, anisotropic micelles showed an approximately fivefold longer half-life in blood circulation than the analogous spherical micelles in a GBM xenograft model in mice. In this model, micelle accumulation to tumors was significantly greater for anisotropic micelle-treated mice compared to spherical micelle-treated mice at both 8 hrs (∼1.8-fold greater, p ≤ 0.001) and 24 hrs (∼2.1-fold greater, p ≤ 0.0001).Conclusion: Overall, this work highlights the promise of a biodegradable anisotropic micelle system to overcome multiple drug delivery challenges and enhance efficacy and safety for the treatment of brain cancer.Keywords: GBM, verteporfin, micelle, anisotropic, poly(ethylene glycol), PEG, poly(beta-amino ester), PBAEhttps://www.dovepress.com/verteporfin-loaded-anisotropic-polybeta-amino-ester-based-micelles-dem-peer-reviewed-article-IJNgbmverteporfinmicelleanisotropicpoly(ethylene glycol) (peg)poly(beta-amino ester) (pbae)
spellingShingle Shamul JG
Shah SR
Kim J
Schiapparelli P
Vazquez-Ramos CA
Lee BJ
Patel KK
Shin A
Quinones-Hinojosa A
Green JJ
Verteporfin-Loaded Anisotropic Poly(Beta-Amino Ester)-Based Micelles Demonstrate Brain Cancer-Selective Cytotoxicity and Enhanced Pharmacokinetics
International Journal of Nanomedicine
gbm
verteporfin
micelle
anisotropic
poly(ethylene glycol) (peg)
poly(beta-amino ester) (pbae)
title Verteporfin-Loaded Anisotropic Poly(Beta-Amino Ester)-Based Micelles Demonstrate Brain Cancer-Selective Cytotoxicity and Enhanced Pharmacokinetics
title_full Verteporfin-Loaded Anisotropic Poly(Beta-Amino Ester)-Based Micelles Demonstrate Brain Cancer-Selective Cytotoxicity and Enhanced Pharmacokinetics
title_fullStr Verteporfin-Loaded Anisotropic Poly(Beta-Amino Ester)-Based Micelles Demonstrate Brain Cancer-Selective Cytotoxicity and Enhanced Pharmacokinetics
title_full_unstemmed Verteporfin-Loaded Anisotropic Poly(Beta-Amino Ester)-Based Micelles Demonstrate Brain Cancer-Selective Cytotoxicity and Enhanced Pharmacokinetics
title_short Verteporfin-Loaded Anisotropic Poly(Beta-Amino Ester)-Based Micelles Demonstrate Brain Cancer-Selective Cytotoxicity and Enhanced Pharmacokinetics
title_sort verteporfin loaded anisotropic poly beta amino ester based micelles demonstrate brain cancer selective cytotoxicity and enhanced pharmacokinetics
topic gbm
verteporfin
micelle
anisotropic
poly(ethylene glycol) (peg)
poly(beta-amino ester) (pbae)
url https://www.dovepress.com/verteporfin-loaded-anisotropic-polybeta-amino-ester-based-micelles-dem-peer-reviewed-article-IJN
work_keys_str_mv AT shamuljg verteporfinloadedanisotropicpolybetaaminoesterbasedmicellesdemonstratebraincancerselectivecytotoxicityandenhancedpharmacokinetics
AT shahsr verteporfinloadedanisotropicpolybetaaminoesterbasedmicellesdemonstratebraincancerselectivecytotoxicityandenhancedpharmacokinetics
AT kimj verteporfinloadedanisotropicpolybetaaminoesterbasedmicellesdemonstratebraincancerselectivecytotoxicityandenhancedpharmacokinetics
AT schiapparellip verteporfinloadedanisotropicpolybetaaminoesterbasedmicellesdemonstratebraincancerselectivecytotoxicityandenhancedpharmacokinetics
AT vazquezramosca verteporfinloadedanisotropicpolybetaaminoesterbasedmicellesdemonstratebraincancerselectivecytotoxicityandenhancedpharmacokinetics
AT leebj verteporfinloadedanisotropicpolybetaaminoesterbasedmicellesdemonstratebraincancerselectivecytotoxicityandenhancedpharmacokinetics
AT patelkk verteporfinloadedanisotropicpolybetaaminoesterbasedmicellesdemonstratebraincancerselectivecytotoxicityandenhancedpharmacokinetics
AT shina verteporfinloadedanisotropicpolybetaaminoesterbasedmicellesdemonstratebraincancerselectivecytotoxicityandenhancedpharmacokinetics
AT quinoneshinojosaa verteporfinloadedanisotropicpolybetaaminoesterbasedmicellesdemonstratebraincancerselectivecytotoxicityandenhancedpharmacokinetics
AT greenjj verteporfinloadedanisotropicpolybetaaminoesterbasedmicellesdemonstratebraincancerselectivecytotoxicityandenhancedpharmacokinetics